Senti Biosciences Inc. has seen no insider trading activity within the last 90 days. The most recent transactions occurred in February 2025, involving sales by the CEO and the President & Chief Medical & Development Officer. Prior to that, a proposed sale was recorded in December 2024 by a former affiliate.